|
This program is designed for clinicians who are interested in developing a collaborative asthma management service.
The goal of this seminar is to provide an update on current evidence-based and practical information that will help pharmacists and other clinicians select, monitor, and ensure optimal outcomes from asthma related drug therapy. At the end of this event, the participants will be better able to:
·Discuss the pharmacology of drugs used in the management of asthma including bronchodilators, anti-inflammatory agents.
·Recognize the changes in pathogens causing respiratory tract infections.
·List the advantages and disadvantages of various antimicrobial agents.
·Discuss strategies to optimize pharmacological therapy for patients with asthma.
·Discuss the process for the development of a comprehensive Asthma Patient Care Program.
·Identify and correct common errors and misconceptions among asthma patients.
Speakers: Steven Chen, PharmD; Craig Jones, MD and George Jaresko, PharmD
The University of Southern California School of Pharmacy is approved by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education. This program was assigned Universal Program Number 007-000-03-001-L01 for 5.0 contact hours, 0.5 CEUs for the March 15 program and 007-000-03-002-L01 for 3.0 contact hours, 0.3 CEUs for the March 16 program. Statements of Credits will be mailed to each program participant 4-6 weeks after the program has been completed.
USC School of Pharmacy is approved by the California State Board of Registered Nursing. Provider Number 13367 for 5.0 hours for March 15 and 3.0 hours for March 16.
Educational support for this seminar is provided by Aventis Pharmaceuticals.
To RSVP, please email your Name, Address, Tel, Fax, Email and Credit Card Payment to eischen@usc.edu.
Please call for pricing information.
More Information:
|
